December 6, 2021

Volume XI, Number 340

Advertisement
Advertisement

December 03, 2021

Subscribe to Latest Legal News and Analysis

White House Announces Relaxation of COVID-19–Related Travel Restrictions to the United States, Beginning on November 8, 2021

As a follow-up to its September 20, 2021 announcement, the White House announced on October 15, 2021, that it would lift the travel ban for fully vaccinated foreign nationals starting November 8, 2021. The lifting of COVID-19–related travel restrictions will apply to land border entries as well as for air travel to the United States.

The new travel policy, which will affect the travel bans currently in place for persons entering the United States from Brazil, China, India, Iran, the Schengen Area countries in Europe, South Africa, and the United Kingdom, will apply only to those travelers who are fully vaccinated. Proof of vaccination and proof of a recent negative COVID-19 test will be required prior to boarding flights to the United States. Likewise, foreign visitors crossing a U.S. land border will need to show proof of vaccination, but not of a recent negative COVID-19 test to enter the United States.

Unvaccinated travelers will still be subject to the travel restrictions put in place in early 2020.

Although details regarding which vaccines will be acceptable for travel purposes have not yet been confirmed by the White House, a U.S. Centers for Disease Control and Prevention (CDC) spokesperson confirmed on October 11, 2021, that only those vaccines approved or authorized by the U.S. Food and Drug Administration (FDA) or listed for emergency use by the World Health Organization (WHO) will be accepted for international travelers seeking to enter the United States. The acceptable vaccines include the following:

  • FDA-Authorized/Approved: Moderna, Johnson & Johnson/Janssen, and Pfizer-BioNTech

  • WHO-Approved: Moderna, Johnson & Johnson/Janssen, Pfizer-BioNTech, Oxford-AstraZeneca, Oxford-AstraZeneca/Covishield, Sinopharm, and Sinovac

© 2021, Ogletree, Deakins, Nash, Smoak & Stewart, P.C., All Rights Reserved.National Law Review, Volume XI, Number 289
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

About this Author

Amy Dalal, Ogletree Deakins Law Firm, Immigration Attorney
Shareholder

Amy Dalal’s practice is primarily concentrated in the areas of business visas and employment-based immigration. She assists employers in obtaining nonimmigrant and immigrant visas for their foreign national employees, including the filing of immigrant visa applications for multinational executives and managers and labor certification filings through the PERM system.  Amy helps multinational corporations with the transfer of personnel from abroad into the United States on temporary work visas.  She also assists companies in preparing for Department of Labor audits, I-9...

919-789-3185
Advertisement
Advertisement
Advertisement